Cite

HARVARD Citation

    Wierzbowska, A. et al. (n.d.). Decitabine improves response rate and prolongs progression‐free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO‐016 trial. American journal of hematology. 93 (5), pp. E125-E127. [Online]. 
  
Back to record